EA201591155A1 - Фармацевтическая композиция, содержащая n-[3-хлор-4-(3-фторбензилокси)фенил]-6-[5({[2-(метилсульфонил)этил]амино}метил)-2-фурил]хиназолин-4-амин или его фармацевтически приемлемые соль, сольват или сольватированную соль - Google Patents
Фармацевтическая композиция, содержащая n-[3-хлор-4-(3-фторбензилокси)фенил]-6-[5({[2-(метилсульфонил)этил]амино}метил)-2-фурил]хиназолин-4-амин или его фармацевтически приемлемые соль, сольват или сольватированную сольInfo
- Publication number
- EA201591155A1 EA201591155A1 EA201591155A EA201591155A EA201591155A1 EA 201591155 A1 EA201591155 A1 EA 201591155A1 EA 201591155 A EA201591155 A EA 201591155A EA 201591155 A EA201591155 A EA 201591155A EA 201591155 A1 EA201591155 A1 EA 201591155A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- ethyl
- amino
- methyl
- furyl
- solvate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к фармацевтической композиции, содержащей N-[3-хлор-4-(3-фторбензилокси)фенил]-6-[5({[2-(метилсульфонил)этил]амино}метил)-2-фурил]хиназолин-4-амин или его фармацевтически приемлемые соль, сольват или сольватированную соль, и к способу приготовления фармацевтической композиции.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13155741 | 2013-02-19 | ||
PCT/EP2014/053087 WO2014128107A1 (en) | 2013-02-19 | 2014-02-18 | Pharmaceutical composition comprising n-[3-chloro-4-(3-fluorobenzyloxy)phenyl]-6-[5({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]quinazolin-4-amine or a pharmaceutically acceptable salt, solvate or solvated salt thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201591155A1 true EA201591155A1 (ru) | 2016-01-29 |
EA029119B1 EA029119B1 (ru) | 2018-02-28 |
Family
ID=47722142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201591155A EA029119B1 (ru) | 2013-02-19 | 2014-02-18 | Фармацевтическая композиция, содержащая n-[3-хлор-4-(3-фторбензилокси)фенил]-6-[5({[2-(метилсульфонил)этил]амино}метил)-2-фурил]хиназолин-4-амин или его фармацевтически приемлемые соль, сольват или сольватированную соль |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2958552B1 (ru) |
CN (1) | CN104981235A (ru) |
EA (1) | EA029119B1 (ru) |
ES (1) | ES2635620T3 (ru) |
IL (1) | IL240136B (ru) |
SI (1) | SI2958552T1 (ru) |
WO (1) | WO2014128107A1 (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106511289A (zh) * | 2015-09-10 | 2017-03-22 | 湖北生物医药产业技术研究院有限公司 | 甲苯磺酸拉帕替尼片剂及其制备方法 |
CN114144168A (zh) * | 2019-07-02 | 2022-03-04 | 奥赖恩公司 | 达鲁酰胺的药物组合物 |
KR20220118432A (ko) * | 2019-12-20 | 2022-08-25 | 주식회사 큐리언트 | Q203의 약학적 경구 투여 형태 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9800569D0 (en) | 1998-01-12 | 1998-03-11 | Glaxo Group Ltd | Heterocyclic compounds |
JP4102185B2 (ja) | 2000-06-30 | 2008-06-18 | グラクソ グループ リミテッド | キナゾリンジトシル酸塩化合物 |
PE20061430A1 (es) * | 2005-04-19 | 2007-01-25 | Smithkline Beecham Cork Ltd | Composicion farmaceutica que comprende compuestos de 4-quinazolinaminas |
EP2158912A1 (en) | 2008-08-25 | 2010-03-03 | Ratiopharm GmbH | Pharmaceutical composition comprising N-[3-chhloro-4-[3-fluorophenyl)methoxy)phenyl]6-[5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4-quinazolinamine |
EP2158913A1 (en) | 2008-08-25 | 2010-03-03 | Ratiopharm GmbH | Pharmaceutical composition comprising N-[3-chhloro-4-[(3-fluorophenyl)methoxy]phenyl]6-(5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4-quinazolinamine |
WO2010099150A1 (en) * | 2009-02-24 | 2010-09-02 | Smithkline Beecham (Cork) Limited | Pharmaceutical tablet and process |
-
2014
- 2014-02-18 ES ES14705162.7T patent/ES2635620T3/es active Active
- 2014-02-18 EA EA201591155A patent/EA029119B1/ru not_active IP Right Cessation
- 2014-02-18 CN CN201480008103.0A patent/CN104981235A/zh active Pending
- 2014-02-18 WO PCT/EP2014/053087 patent/WO2014128107A1/en active Application Filing
- 2014-02-18 EP EP14705162.7A patent/EP2958552B1/en active Active
- 2014-02-18 SI SI201430297T patent/SI2958552T1/sl unknown
-
2015
- 2015-07-23 IL IL240136A patent/IL240136B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP2958552A1 (en) | 2015-12-30 |
IL240136B (en) | 2019-05-30 |
EP2958552B1 (en) | 2017-06-21 |
EA029119B1 (ru) | 2018-02-28 |
SI2958552T1 (sl) | 2017-08-31 |
WO2014128107A1 (en) | 2014-08-28 |
CN104981235A (zh) | 2015-10-14 |
ES2635620T3 (es) | 2017-10-04 |
IL240136A0 (en) | 2015-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018500777A1 (en) | Farnesoid x receptor modulators | |
EA201790389A1 (ru) | Пирролопиримидиновые соединения, используемые в качестве агониста tlr7 | |
BR112015022191A8 (pt) | compostos heteroarila e usos dos mesmos | |
CY1118839T1 (el) | Επικαλυμμενη φαρμακευτικη συνθεση που περιεχει ρεγοραφενιμπη | |
IL237369B (en) | N-]2-(6-fluoro-h1-indol-3-yl)ethyl]-3-(2, 2, 3, 3- tetrafluoropropoxy) benzylamine in combination with an acetylcholinesterase inhibitor for the treatment of Alzheimer's disease | |
EA201790785A1 (ru) | Производные тетрагидроизохинолина | |
EA201691242A1 (ru) | Фармацевтические композиции, содержащие azd9291 | |
EA201591805A1 (ru) | Оксабицикло [2.2.2] кислоты - модуляторы gpr120 | |
PH12016502461A1 (en) | N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide hydrochloride salts | |
EA201892119A1 (ru) | Лекарственный препарат, полученный путем комбинирования агониста fxr и arb | |
PH12017502067A1 (en) | Insecticidal arylpyrrolidines, method for synthesizing same, and use thereof as agents for controlling animal pests | |
CY1124251T1 (el) | Παραγωγα καρβοξαμιδιου | |
ZA201804387B (en) | Pharmaceutical composition containing 2-{4-[n-(5,6- diphenylpyrazin-2-yl)-n-isopropylamino]butyloxy}-n- (methylsulfonyl)acetamide | |
IL230487B (en) | 6-(n-(7-chloro-1-hydroxy-3,1-dihydrobenzo[c][1,2]oxaborole-5-yl)methylsulfonamido)-5-cyclopropyl-2-(4-fluorophenyl)-n- Methylbenzofuran-3-carboxamide, their salts and pharmaceutical preparations containing them | |
EA201492029A1 (ru) | N-этил-4-гидроксил-1-метил-5-(метил(2,3,4,5,6-пентагидроксигексил)амино)-2-оксо-n-фенил-1,2-дигидрохинолин-3-карбоксамид | |
EA201791600A1 (ru) | Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора | |
EA201892264A1 (ru) | Производные тетрагидроизохинолина | |
EA201790838A1 (ru) | Ингибитор киназы aurora a | |
EA201692298A1 (ru) | Производные карбоксамидов | |
EA201491517A1 (ru) | N-этил-n-фенил-1,2-дигидро-4,5-дигидрокси-1-метил-2-оксо-3-хинолинкарбоксамид, его получение и применения | |
EA201591717A1 (ru) | Твердые формы гидрохлорида вемурафениба | |
EA201700356A1 (ru) | Новые циклопропанбензофуранилпиридопиразиндионы | |
DK3259255T3 (da) | (2r,4r)-5-(5'-chlor-2'-fluorbiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazol-2-carbonyl)amino]pentansyre | |
EA201591155A1 (ru) | Фармацевтическая композиция, содержащая n-[3-хлор-4-(3-фторбензилокси)фенил]-6-[5({[2-(метилсульфонил)этил]амино}метил)-2-фурил]хиназолин-4-амин или его фармацевтически приемлемые соль, сольват или сольватированную соль | |
EA201890896A1 (ru) | Твердый препарат для перорального применения, содержащий аморфный солифенацин, и способ его получения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM |